Physician profile
Alyson Lin
NPI 1104278134
$6,122.15
in general payments reported to CMS, 2019-2025
11 companies · $501 in 2025
The $501 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $42.47 · 2021: $49.40 · 2023: $1,720 · 2024: $3,582 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,094 · Travel and Lodging: $2,710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,093.52 |
| Travel and Lodging | $2,710.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,748.60 | 2023-2025 | Total30, Precision 1, Dailies Total1 |
| Coopervision INC. | $966.43 | 2020-2025 | Cvi Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $626.06 | 2023-2024 | Infuse, Biotrue One Day, Infuse Multifocal |
| Johnson & Johnson Vision Care, INC. | $382.94 | 2019-2024 | Acuvue |
| Glaukos Corporation | $138.14 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $119.87 | 2025 | Xdemvy |
| Shire North American Group INC | $57.29 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $25.46 | 2019 | |
| Abbvie INC. | $24.68 | 2023 | |
| Novartis Pharmaceuticals Corporation | $17.87 | 2019 | |
| Sun Pharmaceutical Industries INC. | $14.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyson Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.